Pub Date : 2024-07-19DOI: 10.12775/qs.2024.17.52963
Oliwia Szewczyk, Ewa Olek, Karolina Czarnecka, Anna Korczak, Katarzyna Burda, Emilia Wójcik, Olga Łopacińska, Katarzyna Stańczyk, Aleksandra Korn, Justyna Jędrzejczyk
Introduction: Eating disorders are potentially mortal health conditions affecting mostly young people. The reasons for that in general population are connected to vulnerable self-image, following the current beauty standards and co-existing psychiatric comorbidities. Athletes may be in danger of developing a pathological eating pattern due to sport specific reasons such as higher scores related to thinner body. Aim of study: The main aim of the study was to examine the relationship between eating disorders in professional athletes’ population, evaluate causes and risk factors and to assess health consequences to eating disorder in sport. Materials and methods: This article is based on the literature found in PubMed and Google Scholar Database with the use of keywords such as ”eating disorders”, “sport”, “athletes”, “anorexia nervosa in athletes”, “eating disorders in sport”, “disordered eating in sportsmen”, “female athletes”, “bulimia nervosa”, “binge eating”, “ED and sport”, “mental health and sport”, “consequences of eating disorders”, “sport education”. Results: Investigation of available literature revealed the connection between developing eating disorder in professional athlete sample. The reasons behind it are mostly sports’ oriented and connected to the desire to achieve better results and perfectionism. However, developing an eating disorder results in worse sports’ performance, menstrual irregularity, lower bone mineral density, cardiovascular issues and can be potentially mortal. Conclusion: Athletes are in danger of developing eating disorders. There should be a focus on evaluating people in sport in terms of eating patterns, however available questionnaires are inefficient because players tend to underreport their problems. Coaches and families of the athletes need to be educated in the topic as they can recognize dangerous behaviors first.
{"title":"Eating disorders among professional athletes. A narrative review","authors":"Oliwia Szewczyk, Ewa Olek, Karolina Czarnecka, Anna Korczak, Katarzyna Burda, Emilia Wójcik, Olga Łopacińska, Katarzyna Stańczyk, Aleksandra Korn, Justyna Jędrzejczyk","doi":"10.12775/qs.2024.17.52963","DOIUrl":"https://doi.org/10.12775/qs.2024.17.52963","url":null,"abstract":"Introduction: Eating disorders are potentially mortal health conditions affecting mostly young people. The reasons for that in general population are connected to vulnerable self-image, following the current beauty standards and co-existing psychiatric comorbidities. Athletes may be in danger of developing a pathological eating pattern due to sport specific reasons such as higher scores related to thinner body. \u0000Aim of study: The main aim of the study was to examine the relationship between eating disorders in professional athletes’ population, evaluate causes and risk factors and to assess health consequences to eating disorder in sport. \u0000Materials and methods: This article is based on the literature found in PubMed and Google Scholar Database with the use of keywords such as ”eating disorders”, “sport”, “athletes”, “anorexia nervosa in athletes”, “eating disorders in sport”, “disordered eating in sportsmen”, “female athletes”, “bulimia nervosa”, “binge eating”, “ED and sport”, “mental health and sport”, “consequences of eating disorders”, “sport education”. \u0000Results: Investigation of available literature revealed the connection between developing eating disorder in professional athlete sample. The reasons behind it are mostly sports’ oriented and connected to the desire to achieve better results and perfectionism. However, developing an eating disorder results in worse sports’ performance, menstrual irregularity, lower bone mineral density, cardiovascular issues and can be potentially mortal. \u0000Conclusion: Athletes are in danger of developing eating disorders. There should be a focus on evaluating people in sport in terms of eating patterns, however available questionnaires are inefficient because players tend to underreport their problems. Coaches and families of the athletes need to be educated in the topic as they can recognize dangerous behaviors first. \u0000 ","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141822586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-19DOI: 10.12775/qs.2024.17.53043
Małgorzata Miazga, Jagna Golemo, Barbara Serkis, Zuzanna Bentkowska, Aleksandra Bogoń, Magdalena Ostojska, Izabela Kałuża, Justyna Szpyra, Magdalena Celichowska, Magdalena Górska
Introduction: Fear of falling is described as a natural response to unstable balance resulting problems with postural control. It usually occurs in older people suffering from chronic diseases and lowers their quality of life. Importantly, general physical activity is limited by the fear of falling, which makes everyday functioning difficult. Aim of the study: The aim of this paper is to present and submit the latest discoveries regarding the topic of fear of falling and physical activity. Material and Methods: This article was created based on the PubMed and Scholar database.The literature was reviewed using the keywords: „fear of falling”; „physical activity”. Results: Research shows that there are many chronic diseases, for example diabetic neuropathy, Parkinson's disease or hip fractures, that may predispose patients to fear of falling. The Falls Efficacy Scale - International (FES-I) is one of the several tools to assess fear of falling, which facilitates the selection of appropriate care and interventions. Well-selected exercises such as the Otago programme, can be implemented to reduce this problem. Generally physical activity combined with the proper encouragement to exercise at home is highly effective in reducing the fear of falling. Conclusion: Considering that more and more people may be exposed to the experience fear of falling it seems significant how to combat this problem. There are appropriate methods to assess and interventions which can be implemented to reduce fear of falling by clinicians, but further studies are still needed.
{"title":"Is it possible to tame fear through sport?","authors":"Małgorzata Miazga, Jagna Golemo, Barbara Serkis, Zuzanna Bentkowska, Aleksandra Bogoń, Magdalena Ostojska, Izabela Kałuża, Justyna Szpyra, Magdalena Celichowska, Magdalena Górska","doi":"10.12775/qs.2024.17.53043","DOIUrl":"https://doi.org/10.12775/qs.2024.17.53043","url":null,"abstract":"Introduction: Fear of falling is described as a natural response to unstable balance resulting problems with postural control. It usually occurs in older people suffering from chronic diseases and lowers their quality of life. Importantly, general physical activity is limited by the fear of falling, which makes everyday functioning difficult. \u0000Aim of the study: The aim of this paper is to present and submit the latest discoveries regarding the topic of fear of falling and physical activity. \u0000Material and Methods: This article was created based on the PubMed and Scholar database.The literature was reviewed using the keywords: „fear of falling”; „physical activity”. \u0000Results: Research shows that there are many chronic diseases, for example diabetic neuropathy, Parkinson's disease or hip fractures, that may predispose patients to fear of falling. The Falls Efficacy Scale - International (FES-I) is one of the several tools to assess fear of falling, which facilitates the selection of appropriate care and interventions. Well-selected exercises such as the Otago programme, can be implemented to reduce this problem. Generally physical activity combined with the proper encouragement to exercise at home is highly effective in reducing the fear of falling. \u0000Conclusion: Considering that more and more people may be exposed to the experience fear of falling it seems significant how to combat this problem. There are appropriate methods to assess and interventions which can be implemented to reduce fear of falling by clinicians, but further studies are still needed.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141821711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-19DOI: 10.12775/qs.2024.17.53058
Klara Wojciechowska, Monika Turek, Joanna Skotnicka, Aleksandra Jaroń, Katarzyna Jastrzębska, Karolina Piątkowska, Karolina Błaszczak, Maria Witkowska, Tymoteusz Ślósarz, Maciej Witkowski
Purpose of research: Stress urinary incontinence (SUI) is a common health problem, especially among women which impairs daily functioning. The purpose of this research is to elucidate the pathophysiology of stress urinary incontinence (SUI), describe its diagnostic methods, summarize current treatments in light of recent studies, and outline examples of new potential therapies. Methods: Databases such as PubMed, Medline, and ResearchGate were searched with particular attention to the current guidelines. Basic results: The primary treatment of SUI is lifestyle modification, including weight reduction. Pelvic floor muscle training (PFMT) is recommended as first-line therapy, reducing the number of incontinence episodes and improving quality of life. Additional methods include electrical stimulation or biofeedback. At later stages of treatment, pharmacological therapy is recommended, mainly using vaginal oestrogens and duloxetine. Conclusions: Non-operative therapies, such as lifestyle modification and PFMT, are effective treatments for SUI. In combination with pharmacotherapy, they significantly improve the quality of life of patients without invasive surgical procedures.
研究目的：压力性尿失禁（SUI）是一种常见的健康问题，尤其是在妇女当中，它会影响日常功能。本研究旨在阐明压力性尿失禁（SUI）的病理生理学，描述其诊断方法，根据最新研究总结目前的治疗方法，并概述新的潜在疗法实例。方法：检索了 PubMed、Medline 和 ResearchGate 等数据库，并特别关注了现行指南。基本结果：SUI 的主要治疗方法是改变生活方式，包括减轻体重。建议将盆底肌肉训练（PFMT）作为一线疗法，以减少尿失禁发作次数并改善生活质量。 其他方法包括电刺激或生物反馈。在治疗的后期阶段，建议采用药物疗法，主要使用阴道雌激素和度洛西汀。结论非手术疗法，如改变生活方式和 PFMT，是治疗 SUI 的有效方法。它们与药物疗法相结合，可显著改善患者的生活质量，而无需进行侵入性手术。
{"title":"Non-operative methods for the treatment of female stress urinary incontinence","authors":"Klara Wojciechowska, Monika Turek, Joanna Skotnicka, Aleksandra Jaroń, Katarzyna Jastrzębska, Karolina Piątkowska, Karolina Błaszczak, Maria Witkowska, Tymoteusz Ślósarz, Maciej Witkowski","doi":"10.12775/qs.2024.17.53058","DOIUrl":"https://doi.org/10.12775/qs.2024.17.53058","url":null,"abstract":"Purpose of research: Stress urinary incontinence (SUI) is a common health problem, especially among women which impairs daily functioning. The purpose of this research is to elucidate the pathophysiology of stress urinary incontinence (SUI), describe its diagnostic methods, summarize current treatments in light of recent studies, and outline examples of new potential therapies. \u0000Methods: Databases such as PubMed, Medline, and ResearchGate were searched with particular attention to the current guidelines. \u0000Basic results: The primary treatment of SUI is lifestyle modification, including weight reduction. Pelvic floor muscle training (PFMT) is recommended as first-line therapy, reducing the number of incontinence episodes and improving quality of life. Additional methods include electrical stimulation or biofeedback. At later stages of treatment, pharmacological therapy is recommended, mainly using vaginal oestrogens and duloxetine. \u0000Conclusions: Non-operative therapies, such as lifestyle modification and PFMT, are effective treatments for SUI. In combination with pharmacotherapy, they significantly improve the quality of life of patients without invasive surgical procedures.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141821164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-19DOI: 10.12775/qs.2024.17.53022
Kinga Ziojła-Lisowska, Agnieszka Kuzio, Aleksandra Cieplińska
Incroduction and aim. COPD is a heterogeneous condition characterized by persistent respiratory symptoms. These symptoms can significantly reduce the quality of life for patients. The conventional treatment used so far is not always effective, especially in cases of severe disease and in specific phenotypes, which is why researchers are constantly searching for new drugs. The aim of this paper is to review the published literature on the treatment of COPD, with particular emphasis on the role of biological therapy. Material and methods. Online databases were used for literature research. The review primarily included literature published after 2016. Analysis of the literature. Conventional pharmacological treatment for COPD patients mainly relies on the use of bronchodilators. Recently, researchers have increasingly focused on the potential use of biological therapy in COPD. The greatest hope lies in the broader use of biological therapy in patients with COPD with elevated eosinophil counts. One of the targets is the IL-33/ST2 pathway, which partially directs inflammatory and remodeling processes in COPD. Drugs belonging to this group include tozorakimab, itepekimab, and astegolimab. Another mechanism of action for biological drugs is blocking IL-5; drugs that work through this mechanism include mepolizumab and benralizumab. Dupilumab is a monoclonal antibody that, due to promising research results, currently has the greatest potential for expanding indications for the treatment of COPD. Conclusion. Since biological therapy offers hope for better disease control in specific groups of patients, further clinical research is necessary to explore the use of biological treatment. This could improve the quality of life for individuals with COPD, especially those who respond poorly to conventional treatment. Key words. COPD, chronic obstructive pulmonary disease, biology treatment
{"title":"Treatment of COPD with a particular focus on biological therapy: a systematic review","authors":"Kinga Ziojła-Lisowska, Agnieszka Kuzio, Aleksandra Cieplińska","doi":"10.12775/qs.2024.17.53022","DOIUrl":"https://doi.org/10.12775/qs.2024.17.53022","url":null,"abstract":"Incroduction and aim. COPD is a heterogeneous condition characterized by persistent respiratory symptoms. These symptoms can significantly reduce the quality of life for patients. The conventional treatment used so far is not always effective, especially in cases of severe disease and in specific phenotypes, which is why researchers are constantly searching for new drugs. The aim of this paper is to review the published literature on the treatment of COPD, with particular emphasis on the role of biological therapy. \u0000Material and methods. Online databases were used for literature research. The review primarily included literature published after 2016. \u0000Analysis of the literature. Conventional pharmacological treatment for COPD patients mainly relies on the use of bronchodilators. Recently, researchers have increasingly focused on the potential use of biological therapy in COPD. The greatest hope lies in the broader use of biological therapy in patients with COPD with elevated eosinophil counts. One of the targets is the IL-33/ST2 pathway, which partially directs inflammatory and remodeling processes in COPD. Drugs belonging to this group include tozorakimab, itepekimab, and astegolimab. Another mechanism of action for biological drugs is blocking IL-5; drugs that work through this mechanism include mepolizumab and benralizumab. Dupilumab is a monoclonal antibody that, due to promising research results, currently has the greatest potential for expanding indications for the treatment of COPD. \u0000Conclusion. Since biological therapy offers hope for better disease control in specific groups of patients, further clinical research is necessary to explore the use of biological treatment. This could improve the quality of life for individuals with COPD, especially those who respond poorly to conventional treatment. \u0000Key words. COPD, chronic obstructive pulmonary disease, biology treatment","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141823591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-18DOI: 10.12775/qs.2024.17.52978
Karolina Błaszczak, Adrian Kruszewski, Natalia Paduszyńska, Anna Dąbrowska, Paulina Przybysz, Monika Szyszka, Maja Kucharska
Introduction: Type 1 diabetes is a disease requiring complex treatment: intensive functional insulin therapy with multiple subcutaneous insulin injections (Multiple daily doses of insulin- MDI) or continuous subcutaneous insulin infusion (CSII) with a personal insulin pump. Type 1 diabetes is a disease with many complications including cardiovascular diseases. A key element in good disease control is adequate patient education. This paper will focus on physical activity and its impact on the course of the disease. Aim of the study: To research the impact of physical activity on the course of type 1 diabetes. To reinforce medical professionals' knowledge of exercise management among patients with type 1 diabetes. State of Knowledge: Regular physical exercise is beneficial for diabetes control, at the same time reducing the need for insulin. It also reduces the risk of dangerous late cardiovascular complications. Meta-analyses have shown a significant effect of physical activity on the reduction of HbA1c, BMI, triglycerides and total cholesterol. Continuous glucose monitoring (CGM) systems are recommended for physically active people with type 1 diabetes. Optimal glycaemia at the start and during sport are: for aerobic exercise 126-180 mg/dl (7-10 mmol/l), for anaerobic exercise 90-180 mg/dl (5-10 mmol/l). The reduction in insulin dose depends on the type of exercise, the length of the exercise, the method of treatment, and the pre-exercise blood glucose level. Conclusion: Physical exercise improves the control of type 1 diabetes and therefore reduces the risk of complications of the disease including cardiovascular diseases. Type 1 diabetes is not a contraindication to both amateur and professional sport. However, many variables need to be considered. Every patient with type 1 diabetes must be properly trained before starting exercise.
{"title":"Sport and type 1 diabetes - a great value but also a challenge. Review of the literature and guidelines","authors":"Karolina Błaszczak, Adrian Kruszewski, Natalia Paduszyńska, Anna Dąbrowska, Paulina Przybysz, Monika Szyszka, Maja Kucharska","doi":"10.12775/qs.2024.17.52978","DOIUrl":"https://doi.org/10.12775/qs.2024.17.52978","url":null,"abstract":"Introduction: Type 1 diabetes is a disease requiring complex treatment: intensive functional insulin therapy with multiple subcutaneous insulin injections (Multiple daily doses of insulin- MDI) or continuous subcutaneous insulin infusion (CSII) with a personal insulin pump. Type 1 diabetes is a disease with many complications including cardiovascular diseases. A key element in good disease control is adequate patient education. This paper will focus on physical activity and its impact on the course of the disease. \u0000 \u0000Aim of the study: To research the impact of physical activity on the course of type 1 diabetes. To reinforce medical professionals' knowledge of exercise management among patients with type 1 diabetes. \u0000 \u0000State of Knowledge: Regular physical exercise is beneficial for diabetes control, at the same time reducing the need for insulin. It also reduces the risk of dangerous late cardiovascular complications. Meta-analyses have shown a significant effect of physical activity on the reduction of HbA1c, BMI, triglycerides and total cholesterol. Continuous glucose monitoring (CGM) systems are recommended for physically active people with type 1 diabetes. Optimal glycaemia at the start and during sport are: for aerobic exercise 126-180 mg/dl (7-10 mmol/l), for anaerobic exercise 90-180 mg/dl (5-10 mmol/l). The reduction in insulin dose depends on the type of exercise, the length of the exercise, the method of treatment, and the pre-exercise blood glucose level. \u0000 \u0000Conclusion: Physical exercise improves the control of type 1 diabetes and therefore reduces the risk of complications of the disease including cardiovascular diseases. Type 1 diabetes is not a contraindication to both amateur and professional sport. However, many variables need to be considered. Every patient with type 1 diabetes must be properly trained before starting exercise.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141826311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-18DOI: 10.12775/qs.2024.17.52875
Krzysztof Bilecki, Paulina Cuper, Ilona Jastrzębska, Michał Andrzej Kozicz, Hubert Gugulski, Michał Bado, Patrycja Nowoświat, M. Goncerz
Introduction: The present study investigated the role of fasting and diet in the development and treatment of cancers, with a focus on non-Hodgkin’s lymphomas. Dietary components and regimens have an impact on the risk of development of malignances as well as on the treatment of the disease. Cancerous subtypes react differently to various dietary compounds and regimes. Although not widely used- fasting can be valuable help in cancer treatment. In this article we show how diet modifications and restrictions can affect existing therapies. Aim of the study: By analyzing current literature, the study aimed to understand how various dietary components and regimens influence cancer risk and treatment efficacy. Methods: Extensive research was conducted using PubMed and Google Scholar. References from selected articles were included in the analysis. Results: Consuming high amount of fruits and vegetables, unsaturated fats and supplementing vitamin D can reduce the risk of malignancies, with red meat, dairy products and saturated fats intake increasing it. Fasting affects lipid, glucose, protein and neuroendocrine metabolism in the way that helps the treatment of cancers. It slows down tumor growth, reduces some symptoms and improves the effects of chemotherapy. Exploring this topic further could propagate suitable diets for cancer subtypes as well as popularize fasting, which is not yet a widely known adition to standard anti-cancer treatments.
简介本研究调查了禁食和饮食在癌症发病和治疗中的作用，重点是非霍奇金淋巴瘤。饮食成分和方案对恶性肿瘤的发病风险和治疗都有影响。癌症亚型对各种膳食化合物和疗法的反应各不相同。禁食虽然没有得到广泛应用，但对癌症治疗有重要帮助。在本文中，我们将展示饮食调整和限制对现有疗法的影响：通过分析现有文献，本研究旨在了解各种饮食成分和方案如何影响癌症风险和治疗效果：方法：使用 PubMed 和 Google Scholar 进行了广泛的研究。方法：利用 PubMed 和 Google Scholar 进行了广泛研究，并将所选文章的参考文献纳入分析：结果：摄入大量水果和蔬菜、不饱和脂肪以及补充维生素 D 可以降低患恶性肿瘤的风险，而摄入红肉、乳制品和饱和脂肪则会增加患恶性肿瘤的风险。禁食会影响脂质、葡萄糖、蛋白质和神经内分泌的新陈代谢，有助于癌症的治疗。它能减缓肿瘤生长，减轻某些症状，改善化疗效果。对这一主题的进一步探索可以推广适合癌症亚型的饮食，并普及禁食，因为禁食尚未成为标准抗癌疗法的一个广为人知的补充。
{"title":"Impact of Fasting and Dietary Interventions on the Development and Treatment of Non-Hodgkin’s Lymphomas and Other Cancers - a review","authors":"Krzysztof Bilecki, Paulina Cuper, Ilona Jastrzębska, Michał Andrzej Kozicz, Hubert Gugulski, Michał Bado, Patrycja Nowoświat, M. Goncerz","doi":"10.12775/qs.2024.17.52875","DOIUrl":"https://doi.org/10.12775/qs.2024.17.52875","url":null,"abstract":"Introduction: The present study investigated the role of fasting and diet in the development and treatment of cancers, with a focus on non-Hodgkin’s lymphomas. Dietary components and regimens have an impact on the risk of development of malignances as well as on the treatment of the disease. Cancerous subtypes react differently to various dietary compounds and regimes. Although not widely used- fasting can be valuable help in cancer treatment. In this article we show how diet modifications and restrictions can affect existing therapies.\u0000Aim of the study: By analyzing current literature, the study aimed to understand how various dietary components and regimens influence cancer risk and treatment efficacy.\u0000Methods: Extensive research was conducted using PubMed and Google Scholar. References from selected articles were included in the analysis.\u0000Results: Consuming high amount of fruits and vegetables, unsaturated fats and supplementing vitamin D can reduce the risk of malignancies, with red meat, dairy products and saturated fats intake increasing it. Fasting affects lipid, glucose, protein and neuroendocrine metabolism in the way that helps the treatment of cancers. It slows down tumor growth, reduces some symptoms and improves the effects of chemotherapy. Exploring this topic further could propagate suitable diets for cancer subtypes as well as popularize fasting, which is not yet a widely known adition to standard anti-cancer treatments.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141827726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-18DOI: 10.12775/qs.2024.17.52948
Ilona Jastrzębska, Paulina Cuper, Michał Andrzej Kozicz, Krzysztof Bilecki, Hubert Gugulski, Michał Bado, Patrycja Nowoświat
Introduction: Prader-Willi Syndrome (PWS) is a genetic neurodevelopmental disorder, in which the central clinical characteristics are hyperphagia and obesity. Obesity leads to higher mortality rates in PWS patients and thus, effective and safe treatment of hyperphagia and obesity in PWS individuals is an important aspect of PWS therapy. Aim of the study: The aim of the study was to research both the new and the more standard treatment options of hyperphagia and obesity in PWS patients. Methods and Materials: An extensive literature search was conducted using PubMed database. Only articles from the past 5 years were taken into consideration. The keywords used during the search were: prader willi syndrome, obesity, treatment. Results: Our research showed that in the treatment of hyperphagia and obesity in PWS patients, health professionals may consider the use of pharmacological treatment options, surgery and neuromodulatory options. Moreover, physical activity and environmental control are beneficial in limiting caloric intake and improving body mass index. Furthermore, early diagnosis and thus starting treatment in early childhood are beneficial in preventing the progression of obesity. However, more research is needed to determine which treatment options are best suited for specific patients.
{"title":"The treatment of hyperphagia and obesity in Prader-Willi Syndrome","authors":"Ilona Jastrzębska, Paulina Cuper, Michał Andrzej Kozicz, Krzysztof Bilecki, Hubert Gugulski, Michał Bado, Patrycja Nowoświat","doi":"10.12775/qs.2024.17.52948","DOIUrl":"https://doi.org/10.12775/qs.2024.17.52948","url":null,"abstract":"Introduction: Prader-Willi Syndrome (PWS) is a genetic neurodevelopmental disorder, in which the central clinical characteristics are hyperphagia and obesity. Obesity leads to higher mortality rates in PWS patients and thus, effective and safe treatment of hyperphagia and obesity in PWS individuals is an important aspect of PWS therapy. \u0000Aim of the study: The aim of the study was to research both the new and the more standard treatment options of hyperphagia and obesity in PWS patients. \u0000Methods and Materials: An extensive literature search was conducted using PubMed database. Only articles from the past 5 years were taken into consideration. The keywords used during the search were: prader willi syndrome, obesity, treatment. \u0000Results: Our research showed that in the treatment of hyperphagia and obesity in PWS patients, health professionals may consider the use of pharmacological treatment options, surgery and neuromodulatory options. Moreover, physical activity and environmental control are beneficial in limiting caloric intake and improving body mass index. Furthermore, early diagnosis and thus starting treatment in early childhood are beneficial in preventing the progression of obesity. However, more research is needed to determine which treatment options are best suited for specific patients. ","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141826267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-18DOI: 10.12775/qs.2024.17.52930
Martyna Magdalena Martka, Marta Skorupska, Andrzej Aleksiej, Natalia Aleksandra Popławska, Justyna Śliz, M. Czeczotka, Krzysztof Woźniak
Introduction and Objective. Rheumatoid arthritis (RA) stands as a chronic, systemic autoimmune inflammatory ailment. Lung involvement is one of the most common extra-articular manifestations of RA. Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD) is a severe, progressive disease leading to pulmonary fibrosis, characterized by deterioration of lung function, exacerbation of symptoms and typical radiological features, and early mortality. Review methods and materials This review utilized PubMed, Mendeley by using search terms such as pulmonary fibrosis in rheumatoid arthritis nintedanib treatment, and pulmonary fibrosis in rheumatoid arthritis pirfenidone treatment. All searches were verified by humans, duplicated results and unreliable have been rejected. In addition, case reports and previously established literature reviews were excluded from the review. We used all available original studies evaluating and comparing the efficacy and safety of anti-fibrotic drugs to create this review. Brief description of the state of knowledge In this review, we discuss therapeutic strategies for antifibrotic treatment involving nintedanib and pirfenidone. Furthermore, we compare the efficacy of both drugs, their influence on the extension of life, their safety profiles, and associated side effects based on research findings, and discuss the molecular mechanisms of their action. Summary Clinical trials concerning RA-ILD showed that nintedanib and pirfenidone slow the rate of FVC decline in patients with RA-ILD. The safety profile observed in both drugs was similar simultaneously occurring mainly gastrointestinal symptoms. Both drugs have been approved for the RA-ILD treatment program, nevertheless in the current body of knowledge, it is not feasible to definitively determine which drug therapy should be initiated first, as their characteristics are notably similar.
{"title":"Effectiveness and Safety of Antifibrotic Treatment in Pulmonary Fibrosis Associated with Rheumatoid Arthritis","authors":"Martyna Magdalena Martka, Marta Skorupska, Andrzej Aleksiej, Natalia Aleksandra Popławska, Justyna Śliz, M. Czeczotka, Krzysztof Woźniak","doi":"10.12775/qs.2024.17.52930","DOIUrl":"https://doi.org/10.12775/qs.2024.17.52930","url":null,"abstract":"Introduction and Objective.\u0000Rheumatoid arthritis (RA) stands as a chronic, systemic autoimmune inflammatory ailment. Lung involvement is one of the most common extra-articular manifestations of RA. Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD) is a severe, progressive disease leading to pulmonary fibrosis, characterized by deterioration of lung function, exacerbation of symptoms and typical radiological features, and early mortality.\u0000Review methods and materials\u0000This review utilized PubMed, Mendeley by using search terms such as pulmonary fibrosis in rheumatoid arthritis nintedanib treatment, and pulmonary fibrosis in rheumatoid arthritis pirfenidone treatment. All searches were verified by humans, duplicated results and unreliable have been rejected. In addition, case reports and previously established literature reviews were excluded from the review. We used all available original studies evaluating and comparing the efficacy and safety of anti-fibrotic drugs to create this review.\u0000Brief description of the state of knowledge \u0000In this review, we discuss therapeutic strategies for antifibrotic treatment involving nintedanib and pirfenidone. Furthermore, we compare the efficacy of both drugs, their influence on the extension of life, their safety profiles, and associated side effects based on research findings, and discuss the molecular mechanisms of their action.\u0000 Summary\u0000Clinical trials concerning RA-ILD showed that nintedanib and pirfenidone slow the rate of FVC decline in patients with RA-ILD. The safety profile observed in both drugs was similar simultaneously occurring mainly gastrointestinal symptoms. Both drugs have been approved for the RA-ILD treatment program, nevertheless in the current body of knowledge, it is not feasible to definitively determine which drug therapy should be initiated first, as their characteristics are notably similar.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141826348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-18DOI: 10.12775/qs.2024.17.52984
Adam Kucharski, Konrad Pilarski, Rafał Makuch, Alicja Chrościcka, Kamil Gała, Andrzej Czajka, Paweł Lenard, Sara Michalska, Martyna Dewicka, Alicja Maria Wawrzyniak
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a hereditary heart muscle disorder characterized by the progressive replacement of right ventricular myocardium with fibrofatty tissue. This condition predisposes individuals to arrhythmias and an elevated risk of sudden cardiac death (SCD). The etiology of ARVC is predominantly genetic, with mutations in genes encoding desmosomal proteins playing a crucial role. Physical exercise has a significant impact on the progression of ARVC, often exacerbating the disease's severity and increasing the likelihood of life-threatening arrhythmic events. Diagnosing ARVC remains challenging due to its variable clinical presentation and overlapping features with other cardiomyopathies. Advanced imaging techniques, electrocardiography, and genetic testing are essential tools in the diagnostic process. Treatment strategies for ARVC include lifestyle modifications, pharmacotherapy, implantable cardioverter-defibrillators (ICDs), and in some cases, catheter ablation or heart transplantation. Preventing disease progression and SCD involves a multidisciplinary approach, emphasizing early diagnosis, risk stratification, and tailored therapeutic interventions. This review comprehensively examines the etiology of ARVC, the detrimental effects of physical exercise on the disease, the associated SCD risk, and the challenges in diagnosis, while also discussing current treatment modalities and preventive measures to mitigate disease progression. Materials and Methods Review and summary of research studies available in databases on Google Scholar and PubMed. Databases such as PubMed and Google Scholar were searched using the keywords: ‘Arrhythmogenic right ventricular cardiomyopathy, ‘ARVC in athletes’, ‘Sudden cardiac death’, ‘impact of physical exercise on ARVC’.
{"title":"From Genes to Gym: The Impact of Physical Exercise on Arrhythmogenic Right Ventricular Cardiomyopathy","authors":"Adam Kucharski, Konrad Pilarski, Rafał Makuch, Alicja Chrościcka, Kamil Gała, Andrzej Czajka, Paweł Lenard, Sara Michalska, Martyna Dewicka, Alicja Maria Wawrzyniak","doi":"10.12775/qs.2024.17.52984","DOIUrl":"https://doi.org/10.12775/qs.2024.17.52984","url":null,"abstract":"Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a hereditary heart muscle disorder characterized by the progressive replacement of right ventricular myocardium with fibrofatty tissue. This condition predisposes individuals to arrhythmias and an elevated risk of sudden cardiac death (SCD). The etiology of ARVC is predominantly genetic, with mutations in genes encoding desmosomal proteins playing a crucial role. Physical exercise has a significant impact on the progression of ARVC, often exacerbating the disease's severity and increasing the likelihood of life-threatening arrhythmic events. Diagnosing ARVC remains challenging due to its variable clinical presentation and overlapping features with other cardiomyopathies. Advanced imaging techniques, electrocardiography, and genetic testing are essential tools in the diagnostic process. Treatment strategies for ARVC include lifestyle modifications, pharmacotherapy, implantable cardioverter-defibrillators (ICDs), and in some cases, catheter ablation or heart transplantation. Preventing disease progression and SCD involves a multidisciplinary approach, emphasizing early diagnosis, risk stratification, and tailored therapeutic interventions. This review comprehensively examines the etiology of ARVC, the detrimental effects of physical exercise on the disease, the associated SCD risk, and the challenges in diagnosis, while also discussing current treatment modalities and preventive measures to mitigate disease progression. \u0000Materials and Methods \u0000Review and summary of research studies available in databases on Google Scholar and PubMed. Databases such as PubMed and Google Scholar were searched using the keywords: ‘Arrhythmogenic right ventricular cardiomyopathy, ‘ARVC in athletes’, ‘Sudden cardiac death’, ‘impact of physical exercise on ARVC’.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141826153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-18DOI: 10.12775/qs.2024.17.52932
Justyna Szpyra, Ł. Gawlik, Piotr Jagodowski, Jagna Golemo, Julia Dębińska, Magdalena Ostojska, Magdalena Celichowska, Magdalena Górska, Gabriela Dziuba, Aleksandra Bogoń
Introduction and objective: Endometriosis is a chronic disease that can cause symptoms that significantly worsen the quality of life of patients. Treatment methods often fail to produce satisfactory results. Therefore, there is growing interest in the potential role of diet in prevention and management of endometriosis. The aim of the review is to analyze available scientific literature on the impact of diet on the development and alleviation of endometriosis symptoms and the possibility of its use in clinical practice. Brief description of the state of knowledge: Both nutrient deficiencies and excesses can affect health, with gene-nutrient interactions playing a key role in disease prevention and progression. Nutrition can alter gene expression and disease susceptibility, making the study of diet's influence on gynecological diseases like endometriosis important. Research suggests dietary changes can improve symptoms and quality of life for patients with endometriosis. Conclusions: This study confirms that consuming or limiting some of the nutrients can reduce the risk of developing endometriosis and alleviate its symptoms. However, there are many contradictions in the research. The role of diet and nutrition in endometriosis still remains an unexplored area that requires further investigation.
{"title":"Does diet influence the development and treatment of endometriosis? - A literature review","authors":"Justyna Szpyra, Ł. Gawlik, Piotr Jagodowski, Jagna Golemo, Julia Dębińska, Magdalena Ostojska, Magdalena Celichowska, Magdalena Górska, Gabriela Dziuba, Aleksandra Bogoń","doi":"10.12775/qs.2024.17.52932","DOIUrl":"https://doi.org/10.12775/qs.2024.17.52932","url":null,"abstract":"Introduction and objective: \u0000Endometriosis is a chronic disease that can cause symptoms that significantly worsen the quality of life of patients. Treatment methods often fail to produce satisfactory results. Therefore, there is growing interest in the potential role of diet in prevention and management of endometriosis. The aim of the review is to analyze available scientific literature on the impact of diet on the development and alleviation of endometriosis symptoms and the possibility of its use in clinical practice. \u0000Brief description of the state of knowledge: \u0000Both nutrient deficiencies and excesses can affect health, with gene-nutrient interactions playing a key role in disease prevention and progression. Nutrition can alter gene expression and disease susceptibility, making the study of diet's influence on gynecological diseases like endometriosis important. Research suggests dietary changes can improve symptoms and quality of life for patients with endometriosis. \u0000Conclusions: \u0000This study confirms that consuming or limiting some of the nutrients can reduce the risk of developing endometriosis and alleviate its symptoms. However, there are many contradictions in the research. The role of diet and nutrition in endometriosis still remains an unexplored area that requires further investigation.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141825176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：